These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15351360)

  • 1. Pharmacological chaperone action on G-protein-coupled receptors.
    Bernier V; Bichet DG; Bouvier M
    Curr Opin Pharmacol; 2004 Oct; 4(5):528-33. PubMed ID: 15351360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological chaperones: potential treatment for conformational diseases.
    Bernier V; Lagacé M; Bichet DG; Bouvier M
    Trends Endocrinol Metab; 2004 Jul; 15(5):222-8. PubMed ID: 15223052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific ligands as pharmacological chaperones: The transport of misfolded G-protein coupled receptors to the cell surface.
    Nakamura M; Yasuda D; Hirota N; Shimizu T
    IUBMB Life; 2010 Jun; 62(6):453-9. PubMed ID: 20503438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo.
    Conn PM; Ulloa-Aguirre A; Ito J; Janovick JA
    Pharmacol Rev; 2007 Sep; 59(3):225-50. PubMed ID: 17878512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease.
    Ulloa-Aguirre A; Janovick JA; Brothers SP; Conn PM
    Traffic; 2004 Nov; 5(11):821-37. PubMed ID: 15479448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-protein-coupled receptor trafficking: understanding the chemical basis of health and disease.
    Ulloa-Aguirre A; Janovick JA; Miranda AL; Conn PM
    ACS Chem Biol; 2006 Nov; 1(10):631-8. PubMed ID: 17168568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-associated mutations affect GPR56 protein trafficking and cell surface expression.
    Jin Z; Tietjen I; Bu L; Liu-Yesucevitz L; Gaur SK; Walsh CA; Piao X
    Hum Mol Genet; 2007 Aug; 16(16):1972-85. PubMed ID: 17576745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein synthesis inhibitors and the chemical chaperone TMAO reverse endoplasmic reticulum perturbation induced by overexpression of the iodide transporter pendrin.
    Shepshelovich J; Goldstein-Magal L; Globerson A; Yen PM; Rotman-Pikielny P; Hirschberg K
    J Cell Sci; 2005 Apr; 118(Pt 8):1577-86. PubMed ID: 15784681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting opioid receptors with pharmacological chaperones.
    Petäjä-Repo UE; Lackman JJ
    Pharmacol Res; 2014 May; 83():52-62. PubMed ID: 24355364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid residues of G-protein-coupled receptors critical for endoplasmic reticulum export and trafficking.
    Nakamura M; Yasuda D; Hirota N; Yamamoto T; Yamaguchi S; Shimizu T; Nagamune T
    Methods Enzymol; 2013; 521():203-16. PubMed ID: 23351741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation.
    Petäjä-Repo UE; Hogue M; Bhalla S; Laperrière A; Morello JP; Bouvier M
    EMBO J; 2002 Apr; 21(7):1628-37. PubMed ID: 11927547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoplasmic reticulum stress in the heart.
    Glembotski CC
    Circ Res; 2007 Nov; 101(10):975-84. PubMed ID: 17991891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cure for traffic jams: small molecule chaperones in the endoplasmic reticulum.
    Römisch K
    Traffic; 2004 Nov; 5(11):815-20. PubMed ID: 15479447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug development and the cellular quality control system.
    Conn PM; Janovick JA
    Trends Pharmacol Sci; 2009 May; 30(5):228-33. PubMed ID: 19307028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ER stress and the unfolded protein response.
    Schröder M; Kaufman RJ
    Mutat Res; 2005 Jan; 569(1-2):29-63. PubMed ID: 15603751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misfolded G Protein-Coupled Receptors and Endocrine Disease. Molecular Mechanisms and Therapeutic Prospects.
    Ulloa-Aguirre A; Zariñán T; Jardón-Valadez E
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological chaperones correct misfolded GPCRs and rescue function: protein trafficking as a therapeutic target.
    Maya-Núñez G; Ulloa-Aguirre A; Janovick JA; Conn PM
    Subcell Biochem; 2012; 63():263-89. PubMed ID: 23161143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein misfolding and degradation in genetic diseases.
    Bross P; Corydon TJ; Andresen BS; Jørgensen MM; Bolund L; Gregersen N
    Hum Mutat; 1999; 14(3):186-98. PubMed ID: 10477427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel ubiquitin-dependent quality control in the endoplasmic reticulum.
    Feldman M; van der Goot FG
    Trends Cell Biol; 2009 Aug; 19(8):357-63. PubMed ID: 19631546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive effects of 4-phenylbutyrate on the aggregation of Pael receptors and endoplasmic reticulum stress.
    Kubota K; Niinuma Y; Kaneko M; Okuma Y; Sugai M; Omura T; Uesugi M; Uehara T; Hosoi T; Nomura Y
    J Neurochem; 2006 Jun; 97(5):1259-68. PubMed ID: 16539653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.